(Q41727691)

8 October 2017

1 reference

title

The International Neuroblastoma Risk Groups (INRG): a preliminary report (English)

1 reference

8 October 2017

1 reference

6

1 reference

8 October 2017

P Ambros

3

0 references

Jean Michon

20

object named as

J M Michon

1 reference

8 October 2017

19

K K Matthay

1 reference

8 October 2017

5

G M Brodeur

1 reference

8 October 2017

23

R C Seeger

1 reference

8 October 2017

R P Castleberry

1

1 reference

8 October 2017

J Pritchard

2

1 reference

8 October 2017

F Berthold

4

1 reference

8 October 2017

S L Cohn

7

1 reference

8 October 2017

B De Bernardi

8

1 reference

8 October 2017

C Dicks-Mireaux

9

1 reference

8 October 2017

D Frappaz

10

1 reference

8 October 2017

G M Haase

11

1 reference

8 October 2017

M Haber

12

1 reference

8 October 2017

D R Jones

13

1 reference

8 October 2017

V V Joshi

14

1 reference

8 October 2017

M Kaneko

15

1 reference

8 October 2017

J T Kemshead

16

1 reference

8 October 2017

P Kogner

17

1 reference

8 October 2017

R E Lee

18

1 reference

8 October 2017

R Monclair

21

1 reference

8 October 2017

B R Roald

22

1 reference

8 October 2017

P J Shaw

24

1 reference

8 October 2017

J J Shuster

25

1 reference

8 October 2017

publication date

1 October 1997

1 reference

European Journal of Cancer

8 October 2017

published in

1 reference

8 October 2017

volume

33

1 reference

8 October 2017

issue

12

1 reference

8 October 2017

page(s)

2113-2116

1 reference

International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma

8 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900202-5

7 January 2021

A proposed staging for children with neuroblastoma.Children's cancer study group A

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900202-5

7 January 2021

Surgicopathologic staging of neuroblastoma: prognostic significance of regional lymph node metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900202-5

7 January 2021

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900202-5

7 January 2021

The Pediatric Oncology Group experience with the international staging system criteria for neuroblastoma. Member Institutions of the Pediatric Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900202-5

7 January 2021

Surgical management and outcome of locoregional neuroblastoma: comparison of the Childrens Cancer Group and the international staging systems

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900202-5

7 January 2021

Observations on the histopathology of neuroblastomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900202-5

7 January 2021

Histologic patterns of neuroblastoma related to prognosis and clinical staging

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900202-5

7 January 2021

Prognostic factors in Neuroblastoma. Clinical, histopathologic, and immunohistochemical features and DNA ploidy in relation to prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900202-5

7 January 2021

Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900202-5

7 January 2021

Age-linked prognostic categorization based on a new histologic grading system of neuroblastomas. A clinicopathologic study of 211 cases from the Pediatric Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900202-5

7 January 2021

Serum lactate dehydrogenase in childhood neuroblastoma. A Pediatric Oncology Group recursive partitioning study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900202-5

7 January 2021

10.1016/S0959-8049(97)00202-5

Identifiers

DOI

1 reference

8 October 2017

1 reference